
Turning living neurons into programmable, energy-efficient AI compute.
By Tanmay Verma, Founder · Last verified 03 Jul 2026
In short
Parasma — Turning living neurons into programmable, energy-efficient AI compute. Best for AI researchers exploring alternative compute paradigms, Computational neuroscientists, Technologists interested in bio-hybrid systems. Contact Sales pricing.
See what real users actually say. We scan live discussions, reviews and complaints across the web and hand you an honest verdict — in under a minute.
3 free scans · no card needed · downloadable report
A fascinating R&D project with real proof-of-concept, but currently irrelevant to any practical AI workload. Back YC's bet if you're a long-term research funder; otherwise, check back in a decade.
Compare with: Parasma vs WolframAlpha, Parasma vs Iris.ai, Parasma vs Paxton AI
Last verified: July 2026
Across the latest 1 update: 1 news mention.
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
How likely is Parasma to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →Parasma is a biological compute company that develops algorithms and infrastructure to program living neurons for computational tasks, aiming to create a radically more energy-efficient alternative to silicon-based AI hardware. Backed by Y Combinator, the company cultures neural networks in the lab and trains them to perform tasks like playing Doom, demonstrating a proof-of-concept for biological computing. Their work spans algorithm design for biological neural networks, infrastructure for neural culture maintenance, and ethical frameworks for working with living systems. Parasma is positioned as a pioneering research-stage venture, not a commercial product—ideal for academics and futurists exploring post-silicon compute paradigms, but far from practical for mainstream AI deployment.
Parasma is not a tool you buy, integrate, or deploy. It's a research company with a compelling demo: they trained living neurons to play Doom. That's a genuine breakthrough in bio-compute, but it's still in the petri dish. If you're a computational neuroscientist or an AI ethicist studying consciousness, their publications and ethical consultations are worth tracking. But if you're a developer looking for an API, a marketer automating content, or a business seeking cost savings on inference, walk away—this isn't for you. Compared to conventional AI compute providers (NVIDIA, AWS, Google Cloud), Parasma is not a competitor. Its value proposition is entirely about long-term energy efficiency at the cost of near-zero immediate utility. The company raised YC backing, which gives it credibility, but no product timelines or pricing exist. Buyers should treat this as a speculative research project, not a solution. The real caveat: biological compute is extremely early-stage. Scaling from one culture playing Doom to reliably performing useful AI tasks is a monumental engineering challenge. Ethically, Parasma proactively consults researchers on suffering, which is commendable but adds complexity. For now, Parasma is a name to watch—not a tool to use.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Common stack mates teams adopt alongside Parasma, with the specific reason each pairing earns its keep.
Compute expert-level answers using Wolfram's algorithms, knowledgebase and AI technology.
Used Parasma? Help shape our editorial sentiment research.